Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,359 | 186 | 99.5% |
| Education | $24.80 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sun Pharmaceutical Industries Inc. | $619.36 | 19 | $0 (2023) |
| Allergan, Inc. | $562.14 | 35 | $0 (2021) |
| Shire North American Group Inc | $532.38 | 20 | $0 (2019) |
| Sight Sciences, Inc. | $433.76 | 6 | $0 (2021) |
| TissueTech, Inc. | $421.37 | 3 | $0 (2019) |
| Aerie Pharmaceuticals, Inc. | $347.91 | 12 | $0 (2021) |
| ABBVIE INC. | $341.09 | 15 | $0 (2024) |
| BIOTISSUE HOLDINGS INC. | $288.75 | 2 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $284.73 | 12 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $243.62 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $959.98 | 34 | BIOTISSUE HOLDINGS INC. ($288.75) |
| 2023 | $417.87 | 15 | Johnson & Johnson Surgical Vision, Inc. ($149.41) |
| 2022 | $107.96 | 6 | Alcon Vision LLC ($19.93) |
| 2021 | $529.43 | 26 | Sight Sciences, Inc. ($165.30) |
| 2020 | $758.76 | 22 | Sight Sciences, Inc. ($268.46) |
| 2019 | $1,140 | 48 | Allergan Inc. ($223.24) |
| 2018 | $857.11 | 25 | Shire North American Group Inc ($178.42) |
| 2017 | $613.33 | 12 | Shire North American Group Inc ($152.36) |
All Payment Transactions
188 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: EYE CARE | ||||||
| 12/12/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/25/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Ophthalmology | ||||||
| 09/02/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $93.75 | General |
| 08/29/2024 | Johnson & Johnson Surgical Vision, Inc. | TECNIS IOL (Device) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Optics | ||||||
| 08/28/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/13/2024 | Johnson & Johnson Surgical Vision, Inc. | TECNIS IOL (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Optics | ||||||
| 08/06/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: EYE CARE | ||||||
| 08/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/31/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Ophthalmology | ||||||
| 07/26/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $195.00 | General |
| 07/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: EYE CARE | ||||||
| 07/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/26/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: EYE CARE | ||||||
| 05/29/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: EYE CARE | ||||||
| 05/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/15/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: EYE CARE | ||||||
| 04/30/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/26/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/23/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO, LOTEMAX SM | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Ophthalmology | ||||||
| 04/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: EYE CARE | ||||||
| 04/16/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: SOLUTION/ DROPS | ||||||
| 04/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,233 | 1,535 | $152,069 | $99,921 |
| 2022 | 11 | 555 | 616 | $65,753 | $48,872 |
| 2021 | 12 | 1,108 | 1,357 | $138,401 | $88,462 |
| 2020 | 12 | 1,786 | 2,233 | $215,857 | $146,231 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 298 | 514 | $44,593 | $30,741 | 68.9% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 58 | 84 | $26,101 | $19,270 | 73.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 219 | 226 | $27,195 | $17,153 | 63.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 85 | 85 | $12,206 | $7,865 | 64.4% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 107 | 116 | $6,813 | $4,791 | 70.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 57 | $7,146 | $4,326 | 60.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $5,992 | $3,648 | 60.9% |
| 92134 | Imaging of retina | Office | 2023 | 101 | 128 | $4,929 | $3,452 | 70.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 38 | $7,296 | $2,850 | 39.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 105 | 109 | $3,767 | $2,605 | 69.1% |
| 92250 | Photography of the retina | Office | 2023 | 43 | 46 | $1,642 | $1,117 | 68.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Facility | 2023 | 40 | 41 | $2,655 | $946.69 | 35.7% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 12 | 14 | $826.70 | $521.32 | 63.1% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 23 | 25 | $650.97 | $443.22 | 68.1% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 12 | 14 | $256.48 | $190.71 | 74.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 35 | 51 | $15,904 | $12,201 | 76.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 134 | 174 | $15,201 | $11,575 | 76.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 110 | 110 | $13,364 | $9,351 | 70.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 43 | 43 | $6,285 | $4,546 | 72.3% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 57 | 61 | $3,573 | $2,814 | 78.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $3,665 | $2,783 | 75.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 26 | $3,164 | $2,231 | 70.5% |
| 92134 | Imaging of retina | Office | 2022 | 48 | 49 | $1,881 | $1,453 | 77.3% |
| 92133 | Imaging of optic nerve | Office | 2022 | 52 | 52 | $1,829 | $1,266 | 69.2% |
| 92250 | Photography of the retina | Office | 2022 | 15 | 15 | $542.34 | $380.11 | 70.1% |
About Dr. Brandon Hadel, O.D
Dr. Brandon Hadel, O.D is a Optometrist healthcare provider based in Jenks, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2014. The National Provider Identifier (NPI) number assigned to this provider is 1427462050.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brandon Hadel, O.D has received a total of $5,384 in payments from pharmaceutical and medical device companies, with $959.98 received in 2024. These payments were reported across 188 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,359).
As a Medicare-enrolled provider, Hadel has provided services to 4,682 Medicare beneficiaries, totaling 5,741 services with total Medicare billing of $383,486. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Jenks, OK
- Active Since 06/11/2014
- Last Updated 03/26/2019
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1427462050
Products in Payments
- XIIDRA (Drug) $658.07
- LUMIGAN (Drug) $452.52
- Prokera (Device) $421.37
- OMNI (Device) $268.46
- BROMSITE (Drug) $209.43
- RESTASIS (Drug) $185.70
- Ahmed Glaucoma Valve (Device) $185.24
- VYZULTA (Drug) $177.53
- rhopressa (Drug) $176.02
- OMNI(R) SURGICAL SYSTEM (US) (Device) $165.30
- CEQUA (Drug) $160.40
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $152.59
- DURYSTA (Drug) $137.72
- Tecnis IOL (Device) $137.48
- TEPEZZA (Biological) $133.38
- PROLENSA (Drug) $131.79
- PanOptix (Device) $125.00
- Rhopressa (Drug) $112.40
- XDEMVY (Drug) $112.20
- Cequa (Drug) $96.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Jenks
Mr. Jason Ellen, O.d, O.D
Optometrist — Payments: $10,089
Dr. Sophia Leung, Od, OD
Optometrist — Payments: $8,058
Dr. Mary Sturm, O.d, O.D
Optometrist — Payments: $4,351
Haley Baldridge, Od, OD
Optometrist — Payments: $3,274
Dr. Hannah Sanders, Od, OD
Optometrist — Payments: $2,589
Brittany Wolthuizen, Od, OD
Optometrist — Payments: $1,490